Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Barnet Dulaney Perkins Eye Centers300 enrolled

Overview

Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis

The use of combination Phacoemulsification, OMNI Canaloplasty and Hydrus microstent successfully lowers IOP in ethnically-diverse patients with Open Angle Glaucoma

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Open-Angle Glaucoma

Interventions

Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysisPROCEDURE

The use of combination Phacoemulsification, OMNI Canaloplasty and Hydrus microstent successfully lowers IOP in ethnically-diverse patients with Open Angle Glaucoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data * have Glaucoma Exclusion Criteria: * Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies. * Patients with refractory CME or CME persisting 3 months or more post-operatively * Patients with incomplete IOP, medication logs or VF data within post-operative period * Prior incisional surgery or MIGS

Locations (1)

Barnet Dulaney Perkins Eye Center

Mesa, Arizona, United States

RECRUITING

Outcomes

Primary Outcomes

Measured Efficacy of Surgical Process with Phacoemulsification

Primary endpoint stratified by complete or qualified success: • Proportion of patients with complete success (%) - without the use of medications

Time frame: 24 months